AbCellera Biologics Inc.
2.98
0.21 (7.58%)
At close: Jan 15, 2025, 11:46 AM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY01
PE Ratio -11.28 18.22 25.70 91.19 -3.75K 45.31K n/a
PS Ratio 43.42 5.95 10.51 46.51 781.63 1.59K n/a
PB Ratio 1.43 2.34 3.84 13.06 885.28 1.21K n/a
P/FCF Ratio -13.6 14.11 21.19 1.35K -6.96K -8.04K n/a
P/OCF Ratio -37.63 10.41 16.12 477.95 3.37K 3.93K n/a
OCF/S Ratio -1.15 0.57 0.65 0.10 0.23 0.40 n/a
Debt / Equity Ratio 0.07 0.07 0.04 0.01 0.67 0.30 n/a
Quick Ratio 7.32 8.65 7.69 7.85 1.58 2.36 n/a
Current Ratio 7.33 8.67 7.70 7.86 1.60 2.36 n/a
Asset Turnover 0.03 0.32 0.28 0.23 0.49 0.41 n/a
Interest Coverage n/a 53.53 39.12 23.96 -19.68 -3.55 n/a
Return on Equity (ROE) -0.13 0.13 0.15 0.14 -0.24 0.03 n/a
Return on Assets (ROA) -0.1 0.10 0.12 0.12 -0.1 0.01 n/a
Return on Capital (ROIC) -0.17 0.15 0.17 0.17 -0.26 -0.05 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 86.31% 87.87% 88.36% 12.91% 34.29% n/a
Net Profit Margin -385% 32.66% 40.90% 51.00% -20.84% 3.50% n/a
Pretax Profit Margin -457.67% 49.26% 58.41% 67.69% -19.04% 3.50% n/a
Operating Profit Margin -623.82% 44.60% 54.48% 66.92% -35.46% -8.53% n/a
FCF Margin -319.22% 42.17% 49.61% 3.44% -11.22% -19.73% n/a
EBITDA Margin -505.35% 56.07% 64.40% 72.75% -3.42% 1.87% n/a

Create Price Alert on ABCL

Your price alert will notify you when the stock price is above 2.98.

Add to Watchlist